Upadacitinib 00074-2250-99
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- June 28, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 30 mg/1 |
Selected Package
00074-2250-99Selected30339 TABLET, EXTENDED RELEASE in 1 DRUM (0074-2250-99)